Lumiris — Other

Pelliga, the family office of the Pellicer family behind fertility group IVI, took a minority stake in Lumiris, an IBEC spin-off whose METAPHOR platform combines hyperspectral imaging and AI to non-invasively assess embryo and oocyte metabolic quality for IVF. The stake came from converting earlier financing into direct equity while the company was still advancing a new funding round; no amount or stage was disclosed, and Lumiris had raised roughly €6-8M in total since its 2023 founding.